Research
Education
Healthcare
Community
About
Nov 13, 2023 | Forbes Health
Green Tea vs Black Tea: How Their Health Benefits Compare
A 2021 study by UCI researchers, including Geoffrey W. Abbott, PhD, vice dean of basic science research and professor in the Department of Physiology and Biophysics, is cited in this article about how green and black tea may help regulate high blood pressure.
Nov 09, 2023 | UCI School of Medicine
UC Irvine researchers discover how to better support lab grown muscle cells after transplantation.
Researchers now have the recipe required to make muscle in the lab which can be used to treat a broad range of debilitating muscle disorders.
Nov 08, 2023 | UCI School of Medicine
Bridget Fortin Named Inaugural Estée Lauder Epigenetics Fellow at UCI
Fortin was honored at the Inaugural Paolo Sassone-Corsi Lectureship, held on Oct. 19, at the Arnold and Mabel Beckman Center of the National Academies of Sciences and Engineering in Irvine, Calif.
UCI School of Medicine Research Insider
November 7, 2023
Nov 01, 2023 | UCI School of Medicine
NIH awards $4.4 million to UCI Diabetes Center to study the epigenetic mechanisms for diabetes
Qin Yang, MD, PhD, endocrinologist, director of the UCI Diabetes Center and associate professor in the Departments of Medicine, and Physiology & Biophysics, at the UCI School of Medicine, has received two NIH awards totaling $4.4 million to study the epigenetic mechanisms for diabetes. Wei Li, PhD, professor of bioinformatics in the Department of Biological Chemistry at the UCI School of Medicine, is the co-principal investigator on both awards.
In Memoriam: Kenneth M. Baldwin, PhD
A founding member of the Department of Physiology & Biophysics, which was originally named: Functional Correlates B, Dr. Baldwin was recruited in 1973 to join the faculty at UCI.
October 31, 2023
October 24, 2023
October 17, 2023
Oct 10, 2023 | UCI School of Medicine
University of California, Irvine researchers awarded $2.4 million 'Fast Track' grant to develop a novel cancer immunotherapy treatment
The University of California, Irvine, has been awarded a $2.4 million ‘Fast Track’ Small Business Technology Transfer (STTR) grant from the National Cancer Institute (NCI) to further develop a highly novel cancer immunotherapy treatment. The project, a joint grant with GlyTR Therapeutics Inc, will build upon work at UCI originally funded by the President Biden Cancer Moonshot Program.